Europe Pharmaceutical Packaging Market is expected to grow with the CAGR of 7.1% in the forecast period of 2018 to 2025. The years considered for study are as mentioned below.
Access Full Report at https://www.databridgemarketresearch.com/reports/europe-pharmaceutical-packaging-market
Europe pharmaceutical packaging market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased various strategic developments owing to favourable market scenario.
The major players dealing in Europe pharmaceutical packaging market are introducing strong range of product portfolio. This helped company to maximize the sales with enhanced product portfolio. For instance, In July 2018, Gerresheimer AG acquired Sensile Medical, a Switzerland based manufacturer of Swiss technology for drug delivery devices. Through this acquisition the company aims to expand its drug delivery offering for its Pharmaceutical and Biotech products.
Amcor Limited is the dominating player in Europe pharmaceutical packaging market. The other key players existing in the market includes AptarGroup, Inc, SCHOTT AG, Lonza, DuPont de Nemours, Inc, BAUSCH + STRÖBEL, BD and Gerresheimer AG.
Amcor Limited
Amcor Limited is founded in 1864 and headquartered at Zurich, Switzerland. The company operates through two business segments amcor flexibles, amcor rigid plastics and other/investments. Amcor flexible packaging used in medical and pharmaceutical, fresh produce and snack food segments. Amcor rigid plastics manufactures rigid plastic containers food & beverage products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads and personal care items and plastic caps for a wide variety of applications. The rigid plastics segment focuses on polyethylene terephthalate (PET) packaging as well as plastic resins.
For Instance,
- In June 2019, Amcor announced the acquisition of Bemis Company Inc, the U.S. manufacturer of packaging products. Through this acquisition, the company will able to strengthen its global footprint of food and pharmaceutical packaging business.
The company is having a wide geographical presence in North America, Latin America, Europe, and Asia-Pacific. Amcor Limited has more than 195 subsidiaries across 43 countries. Some of its subsidiaries include Amcor Flexibles (Australia) Pty Limited (Australia), Propack Huizhou Limited (China), Amcor Flexibles Denmark ApS (Denmark), Amcor Packaging Korea Limited (Korea), Amcor Flexibles Reflex Sp z.o.o (Poland), Amcor Flexibles South Africa (Pty) Ltd (South Africa), Amcor Flexibles Rorschach AG (Switzerland), Amcor Flexibles Inc (U.S.) among others.
Gerresheimer AG
Gerresheimer AG is founded in 1864 and headquartered in Dussledorf, Germany is a leading Europe partner to the pharma and healthcare industry. The company operates in two business segments: plastics & devices and primary packaging glass. Plastics & devices division includes complex, customer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and prefillable syringes. Also included are diagnostics and medical technology products such as lancets and test systems, as well as pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems. The primary packaging glass division produces glass primary packaging for medicines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars.
For Instance,
- In July 2017, Gerresheimer announced the launch of new Corning Valor Glass for the pharmaceutical packaging industry. This glass is developed for string and transporting injectable drugs and provides significant protection and strength. With this launch, the company has enhanced its product portfolio in pharmaceutical packaging.
The company's operations span across North America, Europe, Middle East, Africa, Asia, and Rest of the world. Some of the subsidiaries of Gerresheimer AG are Centor(U.S.), Flacor S.A.(U.S.), Kimble Italiana S.P.A.(Italy), Tettauer Glashuttenwerke Gmbh (Germany) among others.
BD
BD is founded in 1897 as Becton, Dickinson and Company and head quartered in New Jersey, U.S., and the company is focused on the diagnostics, delivery of care and medical discovery. The company operates through two business segments: BD medical and BD life sciences. Its medical segment business unit includes diabetes care, medication and procedural solutions, medication management solutions, and pharmaceutical systems. BD medical segment includes needles and syringes, intravenous catheters, self-injection system, insulin syringes and pen needles, prefilled IV flush syringes products.
For instance,
- In December 2017, BD has acquired a C. R. Bard, Inc, the U.S. based manufacturer of medical technologies. Through this acquisition, the company aims to improve their product quality and expand their product portfolio in the market.
The company's operates across North & South America, Europe, Australia, China, India, Japan, Korea, Taiwan and South East Asia. Some of its subsidiaries include Accuri Cytometers, Inc. (Delaware), BD Holding S. de R.L. de C.V. (Mexico), Becton Dickinson AcuteCare Holdings, Inc. (Delaware), Becton Dickinson Asia Limited (Hong Kong), Becton Dickinson Austria GmbH (Austria), CareFusion Corporation (Delaware, and U.K. Medical, Ltd. (U.K.) among others.
